TransMedics Group (TMDX) Reiterated at Hold by Stifel Post ATC Meeting

June 26, 2026 7:53 AM

Stifel analyst Thomas Stephan reiterated a Hold rating and $80.00 price target on TransMedics Group (NASDAQ: TMDX).The analyst commented, "This ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found